Detection and Capture of Circulating Tumor Cells and Other Pathogens
Acousys Biodevices is paving the way to earlier detection and capture of circulating tumor cells (CTCs). Through its patented photoacoustic technology, the company has demonstrated unprecedented performance in identifying and capturing melanoma tumor cells. The technology is applicable to a broad range of cancers, bacteria, viruses and other pathogens.
Springmatter is providing a combination of investment, FDA regulatory guidance, product development, manufacturing, and business support services to accelerate the introduction of Acousys technology into trials.
Learn more at www.Acousysbio.com.